GlassScriptPhysician profile
Keith Alan Bair
NPI 1174639454
$1,309.90
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $598 · 2022: $498 · 2023: $169 · 2024: $44.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $213.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $500.01 | 2021-2023 | |
| Sunovion Pharmaceuticals INC. | $87.02 | 2021-2022 | |
| Novo Nordisk INC | $83.91 | 2021-2022 | |
| Astellas Pharma US INC | $75.27 | 2021-2022 | |
| Gilead Sciences, INC. | $64.74 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $61.35 | 2021-2022 | |
| Lilly USA, LLC | $56.52 | 2023-2024 | Mounjaro, Trulicity |
| Amgen INC. | $50.23 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.44 | 2022 | |
| Merck Sharp & Dohme LLC | $36.11 | 2021 | |
| Xeris Pharmaceuticals, INC. | $34.95 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $30.89 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $30.61 | 2021 | |
| Alexion Pharmaceuticals, INC. | $30.00 | 2021 | |
| Pfizer INC. | $23.31 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $23.06 | 2024 | |
| Almatica Pharma LLC | $19.00 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.06 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.69 | 2021 | |
| Bausch Health US, LLC | $15.90 | 2022 | |
| Amarin Pharma, INC. | $15.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Bair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.